Stocktoria
XBiotech Inc. XBIT
XBiotech Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $4.0M | $18.4M | $44.0M | $0 | $0 | — | — |
| Gross profit | — | — | $0 | $3.4M | $12.6M | $9.4M | $0 | $0 | — | — |
| R&D expense | $47.4M | $37.8M | $32.8M | $31.5M | $28.3M | $9.5M | $24.1M | $15.7M | $26.4M | $42.5M |
| Operating income | -$55.7M | -$42.5M | -$37.5M | -$34.5M | -$25.1M | -$18.3M | -$31.2M | -$21.0M | -$34.1M | -$52.8M |
| Income tax | $235,000 | -$32,000 | $244,000 | -$688,000 | -$8.0M | -$1.6M | $49.8M | $0 | $0 | $0 |
| Net income | -$45.5M | -$38.5M | -$24.6M | -$32.9M | -$17.4M | -$11.2M | $668.6M | -$21.1M | -$33.1M | -$52.8M |
| EPS (diluted) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $14.44 | $-0.59 | $-0.95 | — |
| Operating cash flow | -$39.9M | -$31.0M | -$18.7M | -$14.8M | $69.4M | -$65.1M | -$18.3M | -$16.5M | -$33.6M | -$46.0M |
| Free cash flow | -$40.2M | -$32.3M | -$19.1M | -$15.4M | $65.9M | -$68.9M | -$18.5M | -$16.7M | -$35.1M | -$50.8M |
| Cash & equivalents | $125.6M | $172.7M | $200.0M | $157.3M | $237.0M | $237.4M | $714.6M | $15.8M | $31.8M | $34.3M |
| Total assets | $150.1M | $199.1M | $226.6M | $246.1M | $275.2M | $353.7M | $816.9M | $44.3M | $63.0M | $67.0M |
| Total liabilities | $9.7M | $16.8M | $7.8M | $5.7M | $5.8M | $5.1M | $61.2M | $2.9M | $2.8M | $8.0M |
| Shareholders' equity | $140.3M | $182.3M | $218.8M | $240.4M | $269.4M | $348.6M | $755.6M | $41.4M | $60.2M | $59.1M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -100.0% | -78.2% | -58.2% | — | — | — | — | — |
| Net income growth | — | — | — | — | — | -101.7% | — | — | — | — |
| EPS growth | — | — | — | — | — | -102.5% | — | — | — | — |
| Free cash flow growth | — | — | — | -123.4% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.